Intermezzo is a Sublingual Tablet in the Human Prescription Drug category. It is labeled and distributed by Purdue Pharma Lp. The primary component is Zolpidem Tartrate.
Product ID | 59011-255_227dd91b-5a7f-51d0-3c8f-99182bb8aab5 |
NDC | 59011-255 |
Product Type | Human Prescription Drug |
Proprietary Name | Intermezzo |
Generic Name | Zolpidem Tartrate |
Dosage Form | Tablet |
Route of Administration | SUBLINGUAL |
Marketing Start Date | 2012-04-05 |
Marketing Category | NDA / NDA |
Application Number | NDA022328 |
Labeler Name | Purdue Pharma LP |
Substance Name | ZOLPIDEM TARTRATE |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [CS],Central Nervous System Depression [PE] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-04-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022328 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-04-05 |
Marketing End Date | 2020-05-01 |
Marketing Category | NDA |
Application Number | NDA022328 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-04-05 |
Marketing End Date | 2020-05-01 |
Ingredient | Strength |
---|---|
ZOLPIDEM TARTRATE | 3.5 mg/1 |
SPL SET ID: | 913b6cfe-1fb0-44a8-817a-26374bbce995 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59011-255 | Intermezzo | Intermezzo |
59011-256 | Intermezzo | Intermezzo |
0024-5401 | Ambien | zolpidem tartrate |
0024-5421 | Ambien | zolpidem tartrate |
0024-5501 | Ambien | zolpidem tartrate |
0024-5521 | Ambien | zolpidem tartrate |
0037-6010 | Edluar | Zolpidem Tartrate |
0037-6050 | Edluar | Zolpidem Tartrate |
0054-0086 | Zolpidem Tartrate | zolpidem tartrate |
0054-0087 | Zolpidem Tartrate | zolpidem tartrate |
0093-0073 | Zolpidem Tartrate | Zolpidem Tartrate |
0093-0074 | Zolpidem Tartrate | Zolpidem Tartrate |